Related Experiment Video
Updated: Jan 5, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Contextual Regulation of TGF-β Signaling in Liver Cancer
Shuo Tu1, Wei Huang2, Chunhong Huang3
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, Jiangxi, China. tushuo@126.com.
Abstract:
Primary liver cancer is one of the leading causes for cancer-related death worldwide. Transforming growth factor beta (TGF-β) is a pleiotropic cytokine that signals through membrane receptors and intracellular Smad proteins, which enter the nucleus upon receptor activation and act as transcription factors. TGF-β inhibits liver tumorigenesis in the early stage by inducing cytostasis and apoptosis, but promotes malignant progression in more advanced stages by enhancing cancer cell survival, EMT, migration, invasion and finally metastasis. Understanding the molecular mechanisms underpinning the multi-faceted roles of TGF-β in liver cancer has become a persistent pursuit during the last two decades. Contextual regulation fine-tunes the robustness, duration and plasticity of TGF-β signaling, yielding versatile albeit specific responses. This involves multiple feedback and feed-forward regulatory loops and also the interplay between Smad signaling and non-Smad pathways. This review summarizes the known regulatory mechanisms of TGF-β signaling in liver cancer, and how they channel, skew and even switch the actions of TGF-β during cancer progression.
Insights
Transforming growth factor beta (TGF-β) exhibits dual roles in liver cancer, initially inhibiting tumor growth but later promoting progression and metastasis. Understanding its complex regulation is key to developing targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Primary liver cancer is a major global cause of cancer mortality.
- Transforming growth factor beta (TGF-β) is a cytokine with complex roles in liver cancer.
- TGF-β signaling involves membrane receptors and Smad proteins, impacting gene transcription.
Purpose of the Study:
- To review the molecular mechanisms regulating TGF-β signaling in liver cancer.
- To elucidate how TGF-β's functions shift during cancer progression.
- To understand the interplay of Smad and non-Smad pathways in TGF-β signaling.
Main Methods:
- Literature review of studies on TGF-β signaling in liver cancer.
- Analysis of regulatory mechanisms including feedback loops.
- Examination of Smad and non-Smad pathway interactions.
Main Results:
- TGF-β initially suppresses liver tumorigenesis via cytostasis and apoptosis.
- In advanced stages, TGF-β promotes malignant progression, EMT, invasion, and metastasis.
- Contextual regulation fine-tunes TGF-β signaling responses.
Conclusions:
- TGF-β signaling is dynamically regulated in liver cancer.
- Understanding these regulations is crucial for therapeutic strategies.
- Context-dependent signaling pathways dictate TGF-β's impact on liver cancer progression.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Cell Specific Gene Expression